Skip to main content
Fig. 2 | Journal of Pharmaceutical Health Care and Sciences

Fig. 2

From: Immune checkpoint inhibitor therapy and elevated levels of C-reactive protein associated with COVID-19 aggravation in patients with lung cancer

Fig. 2

Receiver operating characteristic (ROC) analysis of C-reactive protein (CRP) level for respiratory failure. The cutoff value of CRP level for the presence of respiratory failure was determined by the ROC analysis. The cutoff value of CRP level was 2.75 mg/dL, with an area under the curve (AUC) of 0.744, sensitivity of 0.611, and specificity of 0.923

Back to article page